Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers

Journal of Diabetes Research
Li Lai, Yohannes T Ghebremariam

Abstract

Insulin resistance syndrome (IRS) is a configuration of cardiovascular risk factors involved in the development of metabolic disorders including type 2 diabetes mellitus. In addition to diet, age, socioeconomic, and environmental factors, genetic factors that impair insulin signaling are centrally involved in the development and exacerbation of IRS. Genetic and pharmacological studies have demonstrated that the nitric oxide (NO) synthase (NOS) genes are critically involved in the regulation of insulin-mediated glucose disposal. The generation of NO by the NOS enzymes is known to contribute to vascular homeostasis including insulin-mediated skeletal muscle vasodilation and insulin sensitivity. By contrast, excessive inhibition of NOS enzymes by exogenous or endogenous factors is associated with insulin resistance (IR). Asymmetric dimethylarginine (ADMA) is an endogenous molecule that competitively inhibits all the NOS enzymes and contributes to metabolic perturbations including IR. The concentration of ADMA in plasma and tissue is enzymatically regulated by dimethylarginine dimethylaminohydrolase (DDAH), a widely expressed enzyme in the cardiovascular system. In preclinical studies, overexpression of DDAH has been shown to reduc...Continue Reading

References

Jan 1, 1982·Annals of the New York Academy of Sciences·A P Fishman
Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Aug 26, 1998·Clinical and Experimental Immunology·K D KrönckeV Kolb-Bachofen
Jul 17, 1999·The American Journal of Physiology·P Sadri, W W Lautt
Mar 29, 2000·Vascular Medicine·J P Cooke
Mar 21, 2002·JAMA : the Journal of the American Medical Association·Markus C StühlingerPhilip S Tsao
Dec 6, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Maria P GuarinoM Paula Macedo
Aug 30, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Umberto CampiaJulio A Panza
May 4, 2004·British Journal of Anaesthesia·H F Galley, N R Webster
Jan 5, 2005·Journal of Leukocyte Biology·Joan M Cook-Mills, Tracy L Deem
Aug 16, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shu WakinoTakao Saruta
Aug 26, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Friedrich MittermayerMartin Schillinger
Jan 5, 2007·Journal of the American Society of Nephrology : JASN·Takahiko NakagawaByron Croker
May 3, 2007·The Journal of Clinical Endocrinology and Metabolism·Friedrich MittermayerMichael Wolzt
Jul 21, 2007·Free Radical Biology & Medicine·Eleonora DevangelioGiovanni Davì
Oct 16, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Fredrik PalmChristopher S Wilcox
Feb 2, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Karsten SydowJohn P Cooke
Jan 10, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ko HanaiYasuhiko Iwamoto
Feb 21, 2009·Nature Clinical Practice. Endocrinology & Metabolism·Arshag D Mooradian
Mar 21, 2009·Nitric Oxide : Biology and Chemistry·Li Zhou, Dong-Ya Zhu
Apr 7, 2009·Trends in Cardiovascular Medicine·Masato TsutsuiNobuyuki Yanagihara
Jun 30, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M C RichirP A M van Leeuwen
Apr 13, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Maike AnderssohnRainer H Böger
Mar 26, 2011·The Journal of Clinical Investigation·John P Cooke, Yohannes T Ghebremariam
Apr 2, 2011·Nature Reviews. Drug Discovery·James Leiper, Manasi Nandi
Nov 29, 2011·Clinical Science·Benoit ViolletFabrizio Andreelli
Mar 31, 2012·Journal of Biomolecular Screening·Yohannes T GhebremariamJohn P Cooke

❮ Previous
Next ❯

Citations

Jun 2, 2016·The Journal of Physiology·Saskia J H BrinkmannPaul A M van Leeuwen
Jul 6, 2016·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Alejandra B Camargo, Walter Manucha
Dec 12, 2019·Molecular Neurobiology·Alexandre Couto E SilvaHung Wen Lin

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Risk Reduction

Prevention of cardiovascular disease is an important health initiative. Risk reduction including physical activity, smoking cessation, diet, blood pressure lowering drugs and pharmacotherapy. Here is the latest research on cardiovascular risk reduction.

Cardiovascular Homeostasis

Cardiovascular regulation and homeostasis is important in maintaining health and dysfunction may lead to cardiovascular diseases. Nitric oxide and vascular endothelium are one of many molecules involved in the homeostatic mechanism. Here is the latest research on cardiovascular homeostasis.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.